Beijing Shangning Kezhi Medical Equipment Co., Ltd., established on 2021-11-10, Business scope includes licensed projects:Production of Class III Medical Devices;Class III medical device business;Production of Class II Medical Devices.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Sales of Class II Medical Devices;Sales of Class I Medical Devices;Wholesale of computer software, hardware and auxiliary equipment;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Computer System Services;Computer and Office Equipment Repair.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)(Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

OncoNOx ApS provides drugs for the treatment of autoimmune diseases and cancer. It is a pharmaceutical company that transforms marketed drugs into proprietary molecules with anti-cancer and/or anti-inflammatory properties. The firm's projects include OX1001 and OX27-NO is a potent anti-cancer compounds in vitro and in vivo and are intended for the treatment of cancer, and OX1001 also exhibits anti-viral activity and is in development for treatment of human immunodeficiency virus (HIV) and acquired immune deficiency syndrome patients with or without HIV related cancer. The company was founded by Ferdinando Nicoletti, Gianni Garotta, Yousef Al-Abed, Marco Donia, and Mai-Britt Zocca in 2011 and is headquartered in Copenhagen, Denmark.

Chiron Corporation (/ˈkaɪrɒn/ KY-ron) was an American multinational biotechnology firm based in Emeryville, California that was acquired by Novartis on April 20, 2006. It had offices and facilities in eighteen countries on five continents. Chiron's business and research was in three main areas: biopharmaceuticals, vaccines, and blood testing. Chiron's vaccines and blood testing units were combined to form Novartis Vaccines and Diagnostics, while Chiron BioPharmaceuticals was integrated into Novartis Pharmaceuticals. In 2014, Novartis completed the sale of its blood transfusion diagnostics unit to Grifols and announced agreements for the sale of its vaccines unit to GlaxoSmithKline.

Estabished in1950, Snow Brand Milk Products Co. Ltd. is a Japanese dairy company that manufactures cheese, butter, milk and other dairy products. They also manufacture fruit juices and frozen desserts and offers home milk delivery service. Snow Brand has several offices and factories around Japan.

Hayashibara Biochemical Laboratories, Inc. manufactures food and cosmetic products. It also makes health food ingredients, functional dyes, and reagents. The company was founded in 1970 and is headquartered in Okayamashi, Japan.

Zhongshan Ophthalmic Center, part of Sun Yat-Sen University, is a Chinese company located in Guangzhou that operates hospitals.

Kyoto Biken Laboratories, Inc. manufactures veterinary vaccines. It specializes in bovine, porcine, poultry, and plant vaccines. The firm��s business activities include research and development, manufacturing, laboratory diagnosis for field specimens, quality control, after sales validation, and packaging and shipment. The company was founded in June 1948 and is headquartered in Uji, Japan.

Teijin Ltd. engages in the management of its group companies that are involved in the environment and energy, safety and protection, information and electronics, transportation, and healthcare businesses. It operates through the following segments: Materials, Healthcare, and Others. The Materials segment handles the manufacture and sale of polyester, aramid, and carbon fiber products as well as plastic and resin products from polycarbonate resin and polyester film. The Healthcare segment deals with the manufacture and sale of pharmaceuticals and home medical equipment. It also provides home healthcare services. The Others segment offers information technology services. The company was founded by Seita Kumura, Itsuzo Hata, and Naokichi Kaneko on June 17, 1918 and is headquartered in Osaka, Japan.

BioInvent is a research-based pharmaceutical company developing innovative antibody drugs targeting cancers with unmet clinical need.Our drug development programmes are supported by our human antibody development platform. This consists of a proprietary antibody library, n-CoDeR:registered:, and in-house technology for the rapid selection, screening and identification of antibodies with excellent affinity and selectivity for targets. BioInvent has a high level of competence in antibody drug discovery, preclinical and clinical development. The Company also has many years' experience in process development and antibody manufacturing, which we carry out at our own facilities. Alongside our in house and partnered drug-development programmes we offer antibody discovery and development services to customers. BioInvent's business model and technology platform have been validated through numerous partnerships. These include a co-development agreement with Bayer, Daiichi Sankyo, Mitsubishi Tanabe, Servier and others. BioInvent employs around 50 people and is based in Lund, Sweden. The Company listed on the NASDAQ OMX Stockholm in 2001.

Shanghai Sino Biotechnology Co., Ltd., established on 2004-08-26, The scope of business includes technology development in the field of biological expertise,technology transfer,technical consulting,Technical Services,Technical Training,Technical Contracting,technology intermediary,technology investment,Biological product,Chemical Products(In addition to dangerous goods)Production,Sales,Food Sales Management(non-physical means).(involving administrative licensing,The operating permit).

Mochida Pharmaceutical is a drug manufacturing company. Their pharmaceutical business aims to develop and market a broad spectrum of innovative new drugs. They also offer creates skin care products for the general public, and these are supplied through pharmacies, and drugstores.

Tillotts is a leading international specialty pharmaceutical company with an established presence in Europe and in the rest of the world. Tillotts markets its own products such as Asacol™ and Entocort™ as well as in-licensed products in over 65 countries through its affiliates within Europe and a network of gastroenterology-focused partners throughout the world. Tillotts is part of the Japanese Zeria Group.

Shanghai Shangyou Biotechnology Co., Ltd., established on 2008-06-04, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Biomass Energy Technology Services;Research and development of biopesticide technology;Fermentation process optimization technology research and development;Research and development of bio-based materials technology;Sales of bio-based materials;Resource recycling technology research and development;R&D of industrial enzyme preparations;Soil Pollution Control and Restoration Services;Cosmetics Retail;Cosmetics Wholesale;Sales of daily chemical products;Disinfectant sales(Free of Hazardous Chemicals);Personal Hygiene Sales;Sales of hygiene products and single-use medical products;General merchandise sales;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Specialty Chemicals Sales(Free of Hazardous Chemicals);Manufacturing of daily chemical products;Chemical product sales(No licensed chemical products);internet sales(Except for products that require a license for sale);Import and export;Technology Import and Export.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Shanghai Water University Technology Transfer Co., Ltd., established on 2016-06-23, Business scope includes general items:engaged in marine technology,Aquatic technology,food technology,Biological Technology,Ecotechnology,New Energy Technology,computer software,car technology,Electromechanical,mechanical engineering,marine equipment,Ocean engineering,Technical services in the field of ship engineering,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;software development;Computer System Services;Information system integration service;Information Technology Consulting Services;Technology intermediary service;car park service;Intellectual Property Services;Information Consulting Service(Not including licensing information consulting services);Conference and Exhibition Services;Entrepreneurial Space Services;Financial Advisory;Corporate Image Planning;Retailing of computer software, hardware and auxiliary equipment,Sales of mechanical and electrical equipment;electronics sales;Non-residential real estate leases;property management;business management;Import and export;Technology Import and Export.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Excellent Biomedical Technology (Shenzhen) Co., Ltd., established on 2018-11-08, Business scope includes general business items:engaged in biotechnology,Technology development in the field of medical technology,technical consulting,technology transfer;Research and development of biopharmaceutical products,wholesale,Import and export and related supporting business(Commodities that do not involve state trade management,Quota involved,Commodities managed by license management and other special regulations,Apply in accordance with relevant national regulations);Organize medical academic conferences,Exhibitions and related activities.(All of the above are related to the law,Administrative regulations,Except for items prohibited by the State Council,Restricted projects must obtain a license before operating),The licensing program is:

EpimAb Biotherapeutics, Inc. is a Chinese company located in Shanghai that develops bispecific antibodies. It was founded in 2016 by Chen Bing Wu, who has been the CEO since the inception date.\nThe company says this about itself: EpimAb Biotherapeutics is a privately-owned biopharmaceutical R&D company with research and manufacturing facilities in Shanghai and Suzhou with a proprietary unique and efficient technology called FIT-Ig® (Fabs-In-Tandem Immunoglobulin) to generate bispecific molecules with antibody-like properties. With this platform EpimAb is creating a pipeline of its own novel bispecific antibody therapeutics focused around immuno-oncology and other areas of high value to patients. EpimAb is also committed to diversifying its pipeline through selective licensing of its platform and pipeline assets to partners worldwide.

Jinan New Times Pharmaceutical Technology Co., Ltd., established on 2015-10-16, Business scope includes traditional Chinese medicine,Technology Development of Health Food,technology transfer,technical consulting.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shaoguan Galaxy Biotechnology Co., Ltd., established on 2004-06-17, Business scope includes general items:Agricultural Science Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Edible mushroom cultivation;Wholesale of edible agricultural products;Retailing of Edible Agricultural Products;Import and export;Technology Import and Export;Conference and Exhibition Services;business training(Does not include education and training,Vocational skills training and other licensed training).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Edible fungi management;fertilizer production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific operation is subject to the approval documents or licenses of relevant departments)